Angelo Viscido Selected Research

Angelo Viscido Research Topics

Disease

14	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2023 - 01/2004
10	Ulcerative Colitis 01/2021 - 01/2004
9	Crohn Disease (Crohn's Disease) 12/2023 - 01/2004
7	Celiac Disease (Celiac Sprue) 12/2021 - 01/2004
5	Inflammation (Inflammations) 10/2021 - 02/2006
3	Fibrosis (Cirrhosis) 01/2021 - 01/2020
2	Abdominal Pain (Pain, Abdominal) 09/2023 - 01/2003
2	Diarrhea 09/2023 - 01/2003
2	Diverticular Diseases 03/2022 - 01/2003
2	Diverticulitis 03/2022 - 01/2003
2	Hemorrhage 01/2022 - 01/2003
2	Atrophy 12/2021 - 07/2020
2	Colorectal Neoplasms (Colorectal Cancer) 05/2021 - 01/2021
2	Colonic Diseases 03/2020 - 10/2008
1	Immunoglobulin G4-Related Disease 12/2023
1	Pathologic Constriction (Stenosis) 12/2023
1	Anorexia 09/2023
1	Ageusia (Hypogeusia) 09/2023
1	Nausea 09/2023
1	Vomiting 09/2023
1	Overnutrition 08/2023
1	Malnutrition (Nutritional Deficiencies) 08/2023
1	Pericarditis 10/2021
1	COVID-19 12/2020
1	Anemia 07/2020
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 07/2020
1	Chronic Disease (Chronic Diseases) 07/2020
1	Weight Gain 03/2020
1	Non-alcoholic Fatty Liver Disease 03/2020
1	Autoimmune enteropathy 03/2020
1	Body Weight (Weight, Body) 01/2019
1	Hypercholesterolemia 01/2019
1	Hyperglycemia 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Hypertriglyceridemia 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Gastritis 10/2017
1	Disease Progression 10/2017
1	Infections 10/2008
1	Cytomegalovirus Infections (Inclusion Disease) 10/2008
1	Pyoderma Gangrenosum 10/2007
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2007
1	Colitis 02/2007

Drug/Important Bio-Agent (IBA)

8	Infliximab (Remicade)FDA Link 01/2020 - 02/2007
4	Vitamin D FDA LinkGeneric 12/2022 - 01/2021
4	Biosimilar PharmaceuticalsIBA 01/2021 - 01/2019
4	SteroidsIBA 10/2017 - 02/2007
3	MicronutrientsIBA 08/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 05/2021 - 03/2020
3	Glutens (Glutelin)IBA 07/2020 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 08/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2022 - 01/2022
2	AntibodiesIBA 12/2021 - 01/2004
2	TransglutaminasesIBA 12/2021 - 01/2004
2	Adalimumab (Humira)FDA Link 01/2021 - 01/2019
2	C-Reactive ProteinIBA 07/2020 - 03/2020
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2018 - 10/2017
1	Immunoglobulin G (IgG)IBA 12/2023
1	EnzymesIBA 09/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Nucleic AcidsIBA 10/2021
1	Volatile Organic CompoundsIBA 05/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	CalciumIBA 01/2021
1	SeleniumIBA 01/2021
1	LactoferrinIBA 01/2021
1	ABP 501IBA 01/2021
1	IronIBA 07/2020
1	LipidsIBA 03/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 03/2020
1	CT-P13IBA 01/2020
1	Sulfonic AcidsIBA 01/2020
1	pirfenidoneIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	sym-trinitrobenzeneIBA 01/2020
1	CollagenIBA 01/2020
1	Extracellular Matrix ProteinsIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	CytokinesIBA 01/2020
1	HDL CholesterolIBA 01/2019
1	HDL LipoproteinsIBA 01/2019
1	AntioxidantsIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2014
1	DNA (Deoxyribonucleic Acid)IBA 10/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2007
1	Indicators and Reagents (Reagents)IBA 02/2006
1	GadoliniumIBA 02/2006
1	Ferritins (Ferritin)IBA 02/2006
1	Contrast MediaIBA 02/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 02/2007
6	Gluten-Free Diet 12/2021 - 10/2017
2	Remission Induction 08/2023 - 05/2005
2	Colectomy 08/2014 - 02/2007
1	Drug Therapy (Chemotherapy) 01/2021
1	Blood Component Removal (Apheresis) 04/2011
1	Intravenous Injections 02/2006
1	Oral Administration 02/2006